Indivior Pharmaceuticals (INDV) Short-term Investments (2022 - 2025)

Indivior Pharmaceuticals' Short-term Investments history runs 4 years deep, the most recent figure standing at $1.0 million for Q1 2025.

• In Q1 2025, Short-term Investments changed N/A year-over-year to $1.0 million; the TTM figure through Mar 2025 stood at $1.0 million (changed N/A YoY), while the FY2024 annual figure was $1.0 million, down 99.76% from the prior year.
• Short-term Investments was $1.0 million for Q1 2025 at Indivior Pharmaceuticals, roughly flat from $1.0 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $415.0 million in Q4 2023 to a low of $1.0 million in Q4 2024.
• Historically, Short-term Investments has averaged $134.0 million across 4 years, with a median of $60.0 million in 2022.
• The sharpest annual moves came in 2023 and 2024: Short-term Investments surged 248.74% in 2023, then plunged 99.76% in 2024.
• A 4-year view of Short-term Investments shows it stood at $119.0 million in 2022, then soared by 248.74% to $415.0 million in 2023, then slumped by 99.76% to $1.0 million in 2024, then changed by 0.0% to $1.0 million in 2025.
• The last three Short-term Investments figures came in at $1.0 million (Q1 2025), $1.0 million (Q4 2024), and $415.0 million (Q4 2023), per Business Quant data.